ミラバイオロジクス ロゴ

Portfolio

Pipeline

Abbreviations: HGF: hepatocyte Growth Factor, BDNF: brain derived neurotrophic factor, AD: Alzheimer’s Disease, PD: Parkinson’s Disease, NASH: non-alcoholic steatohepatitis, NHP: non-human primate​

Portfolio Creation

We will shape our portfolio through a variety of approaches enabled by LassoGraft Technology®, including

“Plug & play” capability: Connect and function immediately

  • Addition of second/third functions to existing antibodies
  • Granting blood-brain barrier (BBB) permeability

Designing molecules considering topology in three dimensions

  • Creation of agonists with controlled 3D conformation

Giving directionality to gene therapy

  • Central Nervous System (CNS)/cell-directed AAV/Lipid Nano Particle (LNP)

Application to modalities other than immunoglobulins

  • Addition of functions to bioactive proteins such as cytokines